Radio and PodcastRadio and PodcastLive Radio & Podcasts
Training for Clinical Trials with the IMPACT-AD Program artwork
Science & Medicine

Training for Clinical Trials with the IMPACT-AD Program

Dementia Matters by Wisconsin Alzheimer‘s Disease Research Center

Mar 10, 202636:33Science & Medicine

Are you a researcher interested in getting involved in Alzheimer’s disease and related dementias (ADRD) clinical trials? The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD, or IMPACT-AD, pr...

About This Episode

Training for Clinical Trials with the IMPACT-AD Program is an episode from Dementia Matters by Wisconsin Alzheimer‘s Disease Research Center. Are you a researcher interested in getting involved in Alzheimer’s disease and related dementias (...

Podcast

This episode belongs to Dementia Matters.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Mar 10, 2026, 36:33 long, audio available.

Questions About This Episode

What is Training for Clinical Trials with the IMPACT-AD Program about?

Are you a researcher interested in getting involved in Alzheimer’s disease and related dementias (ADRD) clinical trials? The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD, or IMPACT-AD, program brings investigators from around the world together for a week of professional development and education. IMPACT-AD co-directors Dr. Josh Grill and Dr. Rema Raman, as well as faculty member Dr. Maria Carrillo, join the podcast to explain what the program entails, their mission and more. Guests: Josh Grill, PhD, director, Institute for Memory Impairments and Neurological Disorders, professor, University of California, Irvine (UCI), co-director, IMPACT-AD, Rema Raman, PhD, co-director, IMPACT-AD, director, Biostatistics Section and Recruitment, Engagement, and Retention Section, Alzheimer’s Therapeutic Research Institute (ATRI), professor of neurology, University of Southern California (USC), and Maria Carrillo, PhD, chief science officer, medical affairs lead, Alzheimer’s Association, co-principal investigator, Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET), co-principal investigator, Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) Show Notes Learn more and apply for the 2026 IMPACT-AD program on their website . Listen to our previous episode with Rema Raman, “Making an IMPACT: Advancing Alzheimer’s Disease Clinical Trials Through Workforce Development and Inclusivity,” on our website, Spotify , Apple Podcasts and wherever you listen. Listen to our previous episodes with Josh Grill, “The Case for Disclosing Biomarker Results to Alzheimer’s Research Participants” and “Improving Registries and Representation in Alzheimer’s Disease Research” on our website. Read more about Dr. Raman in her USC Keck School of Medicine Profile . Read more about Dr. Grill in his UCI faculty profile . Read more about Dr. Carrillo on the Alzheimer’s Association website . Connect with us Find transcripts and more at our website . Email Dementia Matters : dementiamatters@medicine.wisc.edu

Where can I listen to Training for Clinical Trials with the IMPACT-AD Program?

You can listen to Training for Clinical Trials with the IMPACT-AD Program online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is Training for Clinical Trials with the IMPACT-AD Program from?

Training for Clinical Trials with the IMPACT-AD Program is an episode from Dementia Matters by Wisconsin Alzheimer‘s Disease Research Center.

How long is this episode?

This episode is 36:33 long.

When was this episode published?

This episode was published on Mar 10, 2026.

Can I save Training for Clinical Trials with the IMPACT-AD Program for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from Dementia Matters?

Yes. This page shows related episodes from Dementia Matters when more episodes are available from the podcast feed.